Tumor-associated immune cells hinder frontline chemotherapy drug in pancreatic cancer

(Michigan Medicine - University of Michigan) A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action, research led by the University of Michigan Rogel Cancer Center found.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news